Archive | Consumer Protection

Glass in Atorvastatin Lipitor Generic Drug

Ranbaxy Pharmaceuticals Inc., the company that makes a generic version of the cholesterol-controlling medicine Lipitor, has agreed to stop producing the drug because it is unable to explain why some of the tablets are laced with tiny pieces of glass. Millions of Americans take Lipitor and its generic versions to control their cholesterol, and it […]

Read the full story

Posted in Consumer ProtectionComments Off on Glass in Atorvastatin Lipitor Generic Drug

Hyundai, Kia recall about 270,000 vehicles

  . Reuters (8/15) and the New York (NY) Times (8/14, Jensen, 9.44M) report on the recall of about 270,000 vehicles recalled by Hyundai and Kia in three separate announcements. The affected vehicles are 2006-2011 model Sonata and Azera sedans, 2013 Hyundai Santa Fe Sports, and 2014 Kia Sorrentos. The Hyundai Sonata and Azeras are […]

Read the full story

Posted in Consumer ProtectionComments Off on Hyundai, Kia recall about 270,000 vehicles

Study: no link between tort reform, reduced defensive medicine.

  The Insurance Journal (8/7, 18K) reports that a study in the August Health Affairs “found no consistent relationships” between “physicians’ level of malpractice concern with objective state-level indicators of malpractice liability risk.” Instead, “physicians’ perception of their risk…predicts their practice of defensive medicine,” suggesting “that traditional malpractice reforms, such as caps on damages, don’t […]

Read the full story

Posted in Consumer ProtectionComments Off on Study: no link between tort reform, reduced defensive medicine.

Untitled

    Ford Motors has announced it will issue a recall of about 33,000 2013 C-Max hybrid vehicles due to a failure to meet federal safety standards. The company said that inspections by the NHTSA found the vehicles did not properly protect passengers' heads in a crash. Ford said it has not received any reports […]

Read the full story

Posted in Consumer ProtectionComments Off on Untitled

FDA issues warning on acetaminophen, potentially fatal skin reaction link.

  The Wall Street Journal (8/2, Burton, Subscription Publication, 2.29M) reports that the US Food and Drug Administration issued a safety alert Thursday, to warn healthcare providers and consumers that acetaminophen-based pain relievers and fever reducers, such as Tylenol (acetaminophen) have been linked to several rare but potentially fatal skin reactions, such as Stevens-Johnson syndrome. […]

Read the full story

Posted in Consumer ProtectionComments Off on FDA issues warning on acetaminophen, potentially fatal skin reaction link.

Review: Most malpractice claims caused by medication errors, missed diagnoses.

HealthDay (7/19, Preidt) reports, “Most malpractice claims against primary care doctors are the result of drug errors and missed diagnoses, particularly of cancer, heart attack and meningitis,” according to a review published online July 18 in the journal BMJ Open. After analyzing 34 studies, researchers found that “the most common consequence of missed diagnoses in […]

Read the full story

Posted in Consumer ProtectionComments Off on Review: Most malpractice claims caused by medication errors, missed diagnoses.

Product Safety News

Top Practice Areas

Philadelphia
Mesothelioma, Medical Malpractice, Birth Injury, Spinal Cord Injury, Failure to Diagnose Cancer, Cerebral Palsy, Brain Injury, Personal Injury, Car Accidents, Truck Accidents

New Jersey
Birth Injury, Medical Malpractice, Mesothelioma, Personal Injury, Car Accidents, Truck Accidents

Cohen, Placitella & Roth, P.C.

Archives